Found 49 matching trials
CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease
PHASE1CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B cell mediated...
Location
Children's Hospital, Zhejiang University School of Medicine
UCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological Diseases
EARLY_PHASE1This is a single-arm, open-label, investigator-initiated trial (IIT) design...
Location
Union Hospital, Tongji Medical College, Huazhong University of Science & Technology
PBMC Collection for Production of UCAR T Cells
NAThe objective of the study is to collect peripheral blood mononuclear cells...
Location
First Affiliated Hospital, Soochow University
Safety and Efficacy of Targeted IL-13 Rα2 or B7-H3 UCAR-T for Advanced Glioma
NAThe goal of this clinical trial is to estimate the safety, tolerance and in...
Location
The Second Affiliated Hospital of Soochow University
CD19/BCMA UCAR-T for B Cell-Related Autoimmune Disease
EARLY_PHASE1This is an exploratory, open-label, single-arm clinical study designed to e...
Location
Children's Hospital, Zhejiang University School of Medicine
Efficacy and Safety of CD19 UCAR T Cells in Refractory Systemic Lupus Erythematosus
PHASE1This is an investigator-initiated trial to evaluate the safety and efficacy...
Location
Children's Hospital, Zhejiang University School of Medicine
UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Myasthenia Gravis
EARLY_PHASE1This is an open label, single-site, dose-escalation study in up to 18 parti...
Location
The first affiliated hospital of medical college of zhejiang university
CAR T-cell Therapy Targeting CD19 and BCMA in Patients with AIHA Who Have Failed ≥3 Lines of Therapy.
PHASE1This is an investigator-initiated trial to evaluate the safety and efficacy...
Location
Regenerative Medicine Center and Red Blood Cell Disorders Center
Allogeneic UCB-derived CAR-T for SLE
EARLY_PHASE1The purpose of this clinical trial is to learn if allogeneic, umbilical cor...
Location
Yancheng Third People's Hospital
A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors
PHASE1This is a single-center, single-arm ,open-label ,dose escalation and dose e...
Location
Multiple Locations